A detailed history of Burkehill Global Management, LP transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Burkehill Global Management, LP holds 350,000 shares of BMEA stock, worth $560,000. This represents 0.05% of its overall portfolio holdings.

Number of Shares
350,000
Holding current value
$560,000
% of portfolio
0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$1.37 - $2.9 $479,500 - $1.02 Million
350,000 New
350,000 $630 Million

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $46.9M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Burkehill Global Management, LP Portfolio

Follow Burkehill Global Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burkehill Global Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Burkehill Global Management, LP with notifications on news.